The mainstream media says almost nothing about induced pluripotent stem cells (iPSCs). So, you’re lucky that we’re here to help.

These cells with a clunky name hold the promise of being able to reverse the aging process across our bodies. Put rather bluntly, your old, wine-soaked liver could become like your twenty-something, Jell-O-shot-soaked liver. Your aging neurons could fire like they once did. And your tired heart could be fresh and loving again.

Billions of dollars have been funneled toward trying to figure out how to push iPSCs into our organs safely and effectively. We have not cracked the code yet, but there are signs that scientists are getting closer.

Nabiha Saklayen, the co-founder and CEO of Cellino Bio, is an iPSC whiz and joined the podcast this week to bring us all up to speed on the technology. She covers how iPSCs work, their history and the state of iPSC treatments around the world.

Her company is trying to take iPSCs, which have largely been made by hand, and mass produce them to accelerate experimentation and hopefully therapies and to reduce costs around this fascinating technology.

The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.

This podcast is sponsored by Brex, the intelligent finance platform built to help companies spend smarter and move faster.

We run on Brex and so should you. Learn more about Brex right here.

The podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe

Inside The Race To Reboot Human Cells - EP 60 Nabiha Saklayen

Core Memory